Science Explorer Back to mapMap
Discussion
Topic · Oncology

Pancreatic and Hepatic Oncology Research

Pancreatic and Hepatic Oncology Research is a research topic within Oncology. Science Explorer counts 69k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the research and treatment of pancreatic cancer, covering topics such as surgical complications, chemotherapy regimens (e.g., Gemcitabine), tumor microenvironment, genomic analyses, stromal biology, neoadjuvant therapy, and immunotherapy. The papers also discuss the impact of hospital volume on surgical outcomes and the prevalence of pancreatic cysts.

  • Pancreatic Cancer
  • Surgical Complications
  • Gemcitabine
  • Tumor Microenvironment
  • Genomic Analyses
  • Chemotherapy
  • Stromal Biology
  • Neoadjuvant Therapy
  • Metastatic Pancreatic Cancer
  • Immunotherapy
Research works
69k
fractional, since 1950
In the world top 10%
7k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+8%
the tick is no change
Largest producer
United States
30% of the 10 largest, 2022-now
Pancreatic and Hepatic Oncology Research

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Pancreatic and Hepatic Oncology Research research?

By volume, the United States and China publish the most (4k and 3.2k works in 2022-now).

By volume, 2022-now

  1. 1 United States 4k works
  2. 2 China 3.2k works
  3. 3 Japan 1.7k works
  4. 4 Italy 814 works
  5. 5 India 705 works
  6. 6 Germany 661 works
  7. 7 United Kingdom 636 works
  8. 8 South Korea 551 works
  9. 9 Spain 469 works
  10. 10 France 410 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 30.3%China: 24.3%Japan: 12.9%Italy: 6.2%6 others listed: 26.2%30%largest
United States3,971 · 30.3%China3,185 · 24.3%Japan1,684 · 12.9%Italy814 · 6.2%6 others listed3,432 · 26.2%

Shares of the rows listed above, not of the whole node.

Which institutions lead Pancreatic and Hepatic Oncology Research research?

By volume in 2022-now, Harvard University publishes the most Pancreatic and Hepatic Oncology Research research, followed by Mayo Clinic and The University of Texas MD Anderson Cancer Center.

Who are the leading researchers in Pancreatic and Hepatic Oncology Research?

The most-cited researchers publishing on Pancreatic and Hepatic Oncology Research include Douglas G. Altman, Ahmedin Jemal and Freddie Bray.

  1. 1 Douglas G. Altman United Kingdom 862k citations
  2. 2 Ahmedin Jemal United States 761k citations
  3. 3 Freddie Bray France 550k citations
  4. 4 Eric S. Lander United States 524k citations
  5. 5 Jacques Ferlay France 486k citations
  6. 6 George Davey Smith United Kingdom 435k citations
  7. 7 Ali H. Mokdad United States 429k citations
  8. 8 Walter Churchill Willett United States 411k citations
  9. 9 Stacey L. Gabriel United States 402k citations
  10. 10 Peer Bork Germany 396k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Pancreatic and Hepatic Oncology Research?

The most cited paper in Pancreatic and Hepatic Oncology Research is "Classification of Surgical Complications" (Daniel R. Dindo, Nicolas Demartines, Pierre-Alain Clavien, 2004), with 31,598 citations. Next come "Radiomics: Images Are More than Pictures, They Are Data" (8,616) and "FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer" (7,927).

Most cited papers
#PaperReleasedCitations
1 Classification of Surgical Complications Daniel R. Dindo, Nicolas Demartines, Pierre-Alain Clavien · Annals of Surgery Open access 22 Jul 2004 31,598
2 Radiomics: Images Are More than Pictures, They Are Data Robert J. Gillies, Paul E. Kinahan, Hedvig Hricak · Radiology Open access 18 Nov 2015 8,616
3 FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer Thierry Conroy, Françoise Desseigne, Marc Ychou et al. · New England Journal of Medicine Open access 11 May 2011 7,927
4 TGF-β SIGNAL TRANSDUCTION Joan Massagué · Annual Review of Biochemistry Review Jun 1998 7,585
5 Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States Lola Rahib, Benjamin D. Smith, Rhonda Aizenberg et al. · Cancer Research 20 May 2014 7,367
All 100 most cited papers, with filters and sorting

Where is Pancreatic and Hepatic Oncology Research research done?

The largest centres of Pancreatic and Hepatic Oncology Research research in 2022-now are Beijing (China), Shanghai (China), Tokyo (Japan) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Rozzano, Verona and Wakayama.

Largest cities, 2022-now

  1. 1 BeijingChina 408 works
  2. 2 ShanghaiChina 375 works
  3. 3 TokyoJapan 359 works
  4. 4 SeoulSouth Korea 310 works
  5. 5 New YorkUnited States 233 works
  6. 6 GuangzhouChina 203 works
  7. 7 HoustonUnited States 182 works
  8. 8 HangzhouChina 171 works
  9. 9 NanjingChina 159 works
  10. 10 LondonUnited Kingdom 158 works

Where it is the local speciality

  1. RozzanoIT · 46.1 works18×
  2. VeronaIT · 75.3 works18×
  3. WakayamaJP · 26.3 works17×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Pancreatic and Hepatic Oncology Research than the world average.

See Pancreatic and Hepatic Oncology Research on the map

Where is the best place to study Pancreatic and Hepatic Oncology Research?

Among universities, judged by research, Johns Hopkins University, Harvard University and Sun Yat-sen University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%mean 16.15%fractional works in this field (log) →share of work in the world top 10% →Harvard UniversityJohns Hopkins Univer…University of MichiganSun Yat-sen University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Johns Hopkins UniversityUnited States 79.118.2%4.4×99 -8.0%
2Harvard UniversityUnited States 78.218.3%3.4×157 -13.8%
3Sun Yat-sen UniversityChina 70.814.2%3.9×118 +19.7%
4University of MichiganUnited States 69.518.1%2.6×59 +11.6%
5Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 67.913.5%6.2×96 +24.6%
6University of AmsterdamNetherlands 67.917.9%3.7×32 +7.9%
7Shanghai Jiao Tong UniversityChina 66.315.9%2.4×103 +15.5%
8New York UniversityUnited States 65.714.3%3.0×49 +97.8%
9Fudan UniversityChina 65.018.7%3.5×82 -9.7%
10University of California, San FranciscoUnited States 64.412.4%4.2×44 +24.5%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Pancreatic and Hepatic Oncology Research, country by country

Is Pancreatic and Hepatic Oncology Research research growing?

Output in 2022-2025 was 8% higher than in 2018-2021, peaking in 2024. The fastest-growing topics are Pancreatic and Hepatic Oncology Research.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Pancreatic and Hepatic Oncology Research as a percentage of every work published that year, 0.073% in 2024.

still counting0.050%0.10%Pancreatic and Hepatic Oncology Research0.068% in 202519801990200020102020

Fractional works of Pancreatic and Hepatic Oncology Research over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Pancreatic and Hepatic Oncology Research9.8% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Questions people ask

Which institutions lead pancreatic cancer research?

By volume in 2022-now, Harvard University publishes the most Pancreatic and Hepatic Oncology Research research, followed by Mayo Clinic and The University of Texas MD Anderson Cancer Center.

Which institutions lead Pancreatic and Hepatic Oncology Research research?
All 1,273 questions in the Question Catalogue

Discussion

Ask a question or share a note about Pancreatic and Hepatic Oncology Research. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.